Olson Eric R
Insider CIK 1678149 · SYRS Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2023-07-17 | 2023-07-18 | 689 | $3.50 | $2.4K | 6,661 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-04-03 | 2023-04-04 | 623 | $2.58 | $1.6K | 7,350 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 7,973 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-02-16 | 2023-02-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2022-04-01 | 2022-04-04 | 27,266 | $1.12 | $30.5K | 59,734 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2022-01-05 | 2022-01-06 | 2,208 | $3.47 | $7.7K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2021-07-01 | 2021-07-01 | 1,164 | $5.55 | $6.5K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2021-03-15 | 2021-03-17 | 3,628 | — | $0 | 90,697 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2021-03-15 | 2021-03-17 | 3,628 | $1.01 | $3.7K | 3,628 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2021-03-15 | 2021-03-17 | 3,628 | $9.47 | $34.4K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-02-17 | 2021-02-19 | 94,000 | — | $0 | 94,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2020-08-18 | 2020-08-19 | 10,787 | — | $0 | 94,325 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2020-08-18 | 2020-08-19 | 10,787 | $1.01 | $10.9K | 10,787 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-08-18 | 2020-08-19 | 10,787 | $13.00 | $140.2K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2020-08-17 | 2020-08-19 | 4,963 | — | $0 | 105,112 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-08-17 | 2020-08-19 | 4,963 | $13.00 | $64.5K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2020-08-17 | 2020-08-19 | 4,963 | $1.01 | $5.0K | 4,963 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-07-07 | 2020-07-07 | 1,753 | $11.72 | $20.5K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-02-18 | 2020-02-20 | 1,446 | $7.38 | $10.7K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-02-13 | 2020-02-14 | 94,000 | — | $0 | 94,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-02-12 | 2019-02-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2019-02-12 | 2019-02-14 | 87,000 | — | $0 | 87,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-02-16 | 2018-02-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2017-08-07 | 2017-08-08 | 2,500 | — | $0 | 110,075 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2017-08-07 | 2017-08-08 | 2,500 | $1.01 | $2.5K | 2,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2017-08-07 | 2017-08-08 | 2,500 | $23.59 | $59.0K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2017-07-25 | 2017-07-27 | 12,500 | — | $0 | 25,025 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2017-07-25 | 2017-07-27 | 12,500 | $21.85 | $273.1K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2017-07-25 | 2017-07-27 | 12,500 | $1.01 | $12.6K | 12,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-02-10 | 2017-02-13 | 63,500 | — | $0 | 63,500 | SEC↗ |